Singapore markets closed

Cano Health, Inc. (CANO)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
5.25+0.44 (+9.15%)
At close: 04:00PM EDT
5.36 +0.11 (+2.10%)
Pre-market: 08:33AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.01B
Enterprise value 1.98B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)0.49
Price/book (mrq)2.60
Enterprise value/revenue 0.97
Enterprise value/EBITDA 121.75

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-59.05%
S&P500 52-week change 3-8.83%
52-week high 315.58
52-week low 33.81
50-day moving average 35.19
200-day moving average 37.97

Share statistics

Avg vol (3-month) 33.46M
Avg vol (10-day) 35.81M
Shares outstanding 5207.75M
Implied shares outstanding 6N/A
Float 8158.31M
% held by insiders 124.53%
% held by institutions 177.45%
Shares short (30 May 2022) 420.68M
Short ratio (30 May 2022) 46.32
Short % of float (30 May 2022) 417.96%
Short % of shares outstanding (30 May 2022) 49.95%
Shares short (prior month 28 Apr 2022) 423.23M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022

Profitability

Profit margin -0.06%
Operating margin (ttm)-5.63%

Management effectiveness

Return on assets (ttm)-5.15%
Return on equity (ttm)-22.76%

Income statement

Revenue (ttm)2.04B
Revenue per share (ttm)11.53
Quarterly revenue growth (yoy)156.50%
Gross profit (ttm)198.97M
EBITDA -52.18M
Net income avi to common (ttm)-1.25M
Diluted EPS (ttm)-0.67
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)113.05M
Total cash per share (mrq)0.55
Total debt (mrq)1.09B
Total debt/equity (mrq)129.66
Current ratio (mrq)2.04
Book value per share (mrq)1.88

Cash flow statement

Operating cash flow (ttm)-151.04M
Levered free cash flow (ttm)-91.9M